Skip to main content

Myasthenia Gravis Association's Triple Crown Showdown 5k

Donation Goal: $60,000

The support that the MGA provides to improve the lives of those with myasthenia gravis is important to me because they are able to offer their services 100% free of charge to anybody who needs them.

Myasthenia gravis is a rare autoimmune, neuromuscular disease which impacts 36,000 in 60,000.  The most common symptoms are difficultly with breathing, swallowing, speech, double vision and muscle fatigue.  There is currently no cure.

The MGA works to support the lives of those impacted by myasthenia gravis through support groups, clinics, 1-1 consulations, new patient packets, research, education and awareness events.  Your support ensures that the MGA can continue to provide these tools to support patients along their journey with myasthenia gravis.  The support that the MGA provides to improve the lives of those with myasthenia gravis is important to me because they are able to offer their services 100% free of charge to anybody who needs them.

For more information go to www.mgakc.org

Myasthenia gravis is a rare autoimmune, neuromuscular disease which impacts 36,000-60,000 in the US.  The most common symptoms are difficultly with breathing, swallowing, speech, double vision and muscle fatigue.  There is currently no cure.

The MGA works to support the lives of those impacted by myasthenia gravis through support groups, clinics, 1-1 consultations, new patient packets, research, education and awareness events.  Your support ensures that the MGA can continue to provide these tools to support patients along their journey with myasthenia gravis.  The support that the MGA provides to improve the lives of those with myasthenia gravis is important to me because they are able to offer their services 100% free of charge to anybody who needs them.

For more information go to www.mgakc.org

$0

Raised of $60,000

$0
$60,000

Select a fundraiser to donate to a cause.


Donation

$
Donation Attribution

If you continue to use this site, you consent to use all cookies. We use cookies to offer you a better browsing experience. Read how we use cookies and how you can control them by visiting our Privacy Policy.

If you continue to use this site, you consent to use all cookies.